Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Nieuw consortium voor onderzoek naar immuuntherapie
apr 2025 | Immuuntherapie